Signup Crypto ETF Stocks News

Transaction in Own Shares

LEI: 213800NNT42FFIZB1T09 12 June ...

Source: www.globenewswire.com
June 12, 2025 | 06:00:00
Category: News

Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH

Basel, June 12, 2025 - Novartis announced positive results from APPULSE-PNH, a Phase IIIB study evaluating the efficacy and safety of twice-daily oral monotherapy Fabhalta® ( iptacopan ) in adult patients with paroxysmal nocturnal hemoglobinuria ( PNH ) with Hb levels ≥10g/dL who switched from ...

Source: www.globenewswire.com
June 12, 2025 | 06:00:00
Category: News

KN Energies signs Grant Agreement with the European Commission

International energy terminal operator AB KN Energies ( hereinafter - KN, the Company ) has signed a Grant Agreement with the European Commission to conduct technical and commercial studies for a planned CO2 terminal in Klaipėda.

Source: www.globenewswire.com
June 12, 2025 | 06:00:00
Category: News

Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June

Achieved 58% mean editing at five months after a single dose using high efficiency HSC delivery, demonstrating therapeutically relevant editing levels using a clinically validated strategy.

Source: www.globenewswire.com
June 12, 2025 | 06:01:00
Category: News

Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June - Editas Medicine ( NASDAQ:EDIT )

Achieved 58% mean editing at five months after a single dose using high efficiency HSC delivery, demonstrating therapeutically relevant editing levels using a clinically validated strategy. Achievement supports development of a novel, in vivo approach to treating sickle cell disease and beta ...

Source: www.benzinga.com
June 12, 2025 | 06:01:00
Category: General

US Bancorp studying stablecoins as crypto custody arm sees revival

U.S. Bancorp CEO Gunjan Kedia says her bank is looking into stablecoins as its crypto custody business bounces back after struggling under Biden.

Source: cointelegraph.com
June 12, 2025 | 06:07:03
Category: News

Michael Saylor shares how Covid chaos drove him to Bitcoin

Michael Saylor says pandemic-era lockdowns and unabated money printing pushed him to convert his company's massive cash reserves into Bitcoin.

Source: cointelegraph.com
June 12, 2025 | 06:10:02
Category: News

DeFi Development to refile $1B Solana plan after SEC filing snag

Formerly a real estate financing company, DeFi Development Corp made the switch to become a Solana treasury company, currently holding over 609,000 tokens.

Source: cointelegraph.com
June 12, 2025 | 06:14:17
Category: News

Mandatory notice of shareholding

IDEX Biometrics ASA ( "IDEX" ) discloses the following on behalf of a shareholder.

Source: www.globenewswire.com
June 12, 2025 | 06:15:00
Category: News

© Natavest 2025 - 2026